Coherus Oncology
Commercializes LOQTORZI while advancing mid-stage immuno-oncology antibodies.
$1.39
After-hours close−0.02 (−1.42%)
At close$1.41(−3.42%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.25 | −$0.19 | +24.0% |
| May 2026 | −$0.26 | −$0.25 | +5.1% |
| Mar 2026 | −$0.36 | −$0.34 | +4.2% |
| Nov 2025 | −$0.32 | −$0.33 | −3.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.21 | — | — | $16.0M | — | — |
| Aug 5, 2026 | −$0.25 | −$0.19 | +24.0% | $14.4M | $14.3M | −0.7% |
| May 11, 2026 | −$0.26 | −$0.25 | +5.1% | $14.2M | $12.3M | −13.4% |
| Mar 9, 2026 | −$0.36 | −$0.34 | +4.2% | $13.9M | $12.7M | −8.4% |
| Nov 6, 2025 | −$0.32 | −$0.33 | −3.1% | $14.1M | $11.6M | −17.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 10, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 13, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 8, 2023 | ||||||
| Mar 6, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 17, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 24, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 27, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 8, 2018 | ||||||
| Nov 6, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 8, 2017 | ||||||
| Mar 13, 2017 | ||||||
| Nov 9, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 9, 2016 | ||||||
| Feb 29, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 10, 2015 | ||||||